je.st
news
Drug for relapsing forms of MS, Tecfidera approved: what's next for patients?
2013-04-22 03:58:28| Biotech - Topix.net
The third oral drug to treat relapsing remitting Multiple Sclerosis, Tecfidera, aka BG-12 from manufacturer Biogen Idec , was approved by the FDA March 27, 2013.
Tags: next
forms
approved
drug
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||